中文

← All funding rounds

INFevo

ChinaDrug discoveryBeijing, ChinaFounded 2025Private

Builds virtual-cell models (OCOO; OCOO-T predicts how a cell's gene expression changes under a drug, a gene knockdown or a cytokine), a hypothesis engine (The Popper Project) and a research workbench, run in a loop with its own automated lab for cell culture, perturbation and omics; incubated by XtalPi.

Disclosed total-
Rounds on record2
Latest roundover 100 million yuanPre-A · 2026-11-16
Last stated valuationNone stated
Investors named8
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2027AngelPre-A
Closed roundNot on the dollar scale (a range, or no rate)

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-11-16Pre-A
    Round

    over 100 million yuan

    For: base-model R&D, a larger high-throughput automated wet-dry lab loop, and industry partnerships

    Models and platformWet labAutomated lab

    36Kr's first report, with the company's statements, read on 36Kr's NetEase account; 36Kr says the investors invested jointly and names no lead. The 36Kr report names Lipeng Lai as a co-founder of INFevo; that he is XtalPi's co-founder of that name is the record's reading, as XtalPi incubated the company.

    Xinglian CapitalProsperity7 (Aramco)Huagai CapitalT-CapitalDT Capital PartnersExisting investor · Shunwei CapitalExisting investor · HSG (Sequoia China)Existing investor · Green Pine Capital Partners

  2. 2026-06-01Angel
    Round

    tens of millions of yuan

    Not stated

    Announced by XtalPi, the incubator; the three investors 'took part together', none named as lead. XtalPi's 2026 interim results repeat the round.

    Shunwei CapitalHSG (Sequoia China)Green Pine Capital Partners

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.